Chronos Wealth Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.13M Sell
32,017
-191
-0.6% -$44.5K 3.61% 11
2026
Q1
$7.87M Sell
32,208
-278
-0.9% -$64.8K 3.81% 11
2025
Q4
$6.72M Sell
32,486
-102
-0.3% -$20.2K 3.11% 12
2025
Q3
$6.04M Sell
32,588
-592
-2% -$101K 2.96% 14
2025
Q2
$5.07M Buy
33,180
+34
+0.1% +$5.23K 2.63% 19
2025
Q1
$5.5M Sell
33,146
-390
-1% -$61K 2.95% 15
2024
Q4
$4.85M Sell
33,536
-611
-2% -$94.7K 2.48% 18
2024
Q3
$5.53M Buy
34,147
+50
+0.1% +$7.97K 2.89% 17
2024
Q2
$4.98M Sell
34,097
-737
-2% -$110K 2.77% 17
2024
Q1
$5.51M Sell
34,834
-227
-0.6% -$36.1K 3.22% 16
2023
Q4
$5.5M Buy
35,061
+98
+0.3% +$15K 3.5% 14
2023
Q3
$5.45M Buy
34,963
+506
+1% +$83.5K 3.81% 11
2023
Q2
$5.7M Buy
34,457
+45
+0.1% +$7.26K 3.95% 12
2023
Q1
$5.33M Buy
34,412
+294
+0.9% +$47.5K 4% 13
2022
Q4
$6.03M Buy
34,118
+27
+0.1% +$4.66K 4.76% 9
2022
Q3
$5.57M Sell
34,091
-306
-0.9% -$51.8K 4.61% 10
2022
Q2
$6.11M Sell
34,397
-193
-0.6% -$34.4K 4.58% 7
2022
Q1
$6.13M Buy
34,590
+304
+0.9% +$51.7K 3.9% 9
2021
Q4
$5.87M Buy
34,286
+670
+2% +$110K 3.55% 12
2021
Q3
$5.43M Buy
33,616
+110
+0.3% +$18.8K 3.69% 12
2021
Q2
$5.52M Buy
33,506
+901
+3% +$149K 3.79% 11
2021
Q1
$5.36M Buy
32,605
+769
+2% +$124K 4.06% 11
2020
Q4
$5.01M Buy
31,836
+918
+3% +$135K 4.11% 10
2020
Q3
$4.6M Buy
30,918
+340
+1% +$50.3K 4.14% 10
2020
Q2
$4.3M Buy
30,578
+120
+0.4% +$17.5K 4.16% 9
2020
Q1
$3.99M Sell
30,458
-563
-2% -$79.9K 4.6% 8
2019
Q4
$4.53M Buy
+31,021
New +$4.21M 4.44% 9

Other funds holding JNJ

Chronos Wealth Management's JNJ Position: Q2 2026 in Review

Chronos Wealth Management reduced its Johnson & Johnson (JNJ) stake by 0.59% in Q2 2026, selling an estimated $44.5K and leaving 32,017 shares worth $8.13M. The position accounts for 3.61% of the portfolio, ranked #11.

Chronos Wealth Management first reported a position in JNJ in Q4 2019 and has held it in 27 quarters since. 2,235 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Chronos Wealth Management held 32,017 shares of Johnson & Johnson worth $8.13M as of Q2 2026.
  • Chronos Wealth Management sold 191 Johnson & Johnson shares in Q2 2026, an estimated $44.5K.
  • Johnson & Johnson made up 3.61% of Chronos Wealth Management's portfolio in Q2 2026, its #11 holding.
  • Chronos Wealth Management first reported a position in Johnson & Johnson in Q4 2019 and has held it in 27 quarters since.
  • 2,235 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Chronos Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.